These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27635961)

  • 1. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Primary Management of Patients With Nonfunctioning Pituitary Adenomas.
    Lucas JW; Bodach ME; Tumialan LM; Oyesiku NM; Patil CG; Litvack Z; Aghi MK; Zada G
    Neurosurgery; 2016 Oct; 79(4):E533-5. PubMed ID: 27635961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental versus symptomatic nonfunctioning pituitary adenomas: Are they different?
    Guerreiro V; Mendonça F; Urbano Ferreira H; Freitas P; Pereira J; Bernardes I; Pinheiro J; Guimarães T; Carvalho D
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e445. PubMed ID: 37697708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pituitary adenomas: a matched-cohort analysis.
    Mantziaris G; Pikis S; Chytka T; Liščák R; Sheehan K; Sheehan D; Peker S; Samanci Y; Bindal SK; Niranjan A; Lunsford LD; Kaur R; Madan R; Tripathi M; Pangal DJ; Strickland BA; Zada G; Langlois AM; Mathieu D; Warnick RE; Patel S; Minier Z; Speckter H; Xu Z; Kormath Anand R; Sheehan JP
    J Neurosurg; 2023 Jun; 138(6):1662-1668. PubMed ID: 36401547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing redo surgery and stereotactic radiosurgery for recurrent, residual, and/or tumors showing progression in nonfunctioning pituitary adenomas: A systematic review and meta-analysis.
    Islam MYU; Akhtar S; Nasir R; Anis SB; Iftikhar H; Khan FR; Martins RS; Bari ME; Ahmed U
    Surg Neurol Int; 2024; 15():37. PubMed ID: 38468659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory nonfunctioning pituitary adenomas.
    Kolitz T; Greenman Y
    Pituitary; 2023 Jun; 26(3):278-280. PubMed ID: 36786972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Treatment of Non-Functioning Pituitary Adenomas.
    Vargas-Ortega G; Gonzalez-Virla B; Romero-Gameros CA
    Arch Med Res; 2023 Dec; 54(8):102917. PubMed ID: 37996269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcomes of conservatively observed asymptomatic nonfunctioning pituitary adenomas with optic nerve compression.
    Hwang K; Kim YH; Kim JH; Lee JH; Yang HK; Hwang JM; Kim CY; Han JH
    J Neurosurg; 2021 Jun; 134(6):1808-1815. PubMed ID: 32502994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas.
    Ayalon-Dangur I; Turjeman A; Hirsch D; Robenshtok E; Tsvetov G; Gorshtein A; Masri H; Shraga-Slutzky I; Manisterski Y; Akirov A; Shimon I
    Pituitary; 2024 Feb; 27(1):52-60. PubMed ID: 38064148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.
    Hallén T; Johannsson G; Thorsell A; Olsson DS; Örndal C; Engvall A; Jacobson F; Widgren A; Bergquist J; Skoglund T
    J Clin Endocrinol Metab; 2024 May; 109(6):1485-1493. PubMed ID: 38157275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-and post-surgical non-functional pituitary adenomas and their relationship with high levels of serum glucose.
    Flores-Rabasa R; González-Almazán JA; Cortés-Contreras AP; Méndez-García LA; Velasco F; Navarro-Olvera JL; Aguado-Carrillo G; Benítez-Gasca A; Gómez-Apo E; Carrillo-Ruiz JD
    Int J Neurosci; 2024 May; ():1-8. PubMed ID: 38742394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of older age with better progression-free survival despite less aggressive resection in nonfunctioning pituitary adenomas.
    Shinya Y; Atkinson JLD; Erickson D; Bancos I; Pinheiro Neto CD; Davidge-Pitts CJ; Peris Celda M; Herndon JS; Hong S; Van Gompel JJ
    J Neurosurg; 2024 Sep; 141(3):781-789. PubMed ID: 38669710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric Assessment of Nonfunctional Pituitary Adenoma Treated With Stereotactic Radiosurgery: An Assessment of Long-Term Response.
    Dayawansa S; Abbas SO; Mantziaris G; Dumot C; Donahue JH; Sheehan JP
    Neurosurgery; 2023 Dec; 93(6):1339-1345. PubMed ID: 37437306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary incidentaloma: an endocrine society clinical practice guideline.
    Freda PU; Beckers AM; Katznelson L; Molitch ME; Montori VM; Post KD; Vance ML;
    J Clin Endocrinol Metab; 2011 Apr; 96(4):894-904. PubMed ID: 21474686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Aberrant DNA Methylation in Misregulation of Gene Expression in Gonadotroph Nonfunctioning Pituitary Tumors.
    Kober P; Boresowicz J; Rusetska N; Maksymowicz M; Paziewska A; Dąbrowska M; Kunicki J; Bonicki W; Ostrowski J; Siedlecki JA; Bujko M
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
    Long Y; Lu M; Cheng T; Zhan X; Zhan X
    Front Endocrinol (Lausanne); 2019; 10():835. PubMed ID: 31920959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary Adenoma in the Philippines: A Scoping Review on the Treatment Gaps, Challenges, and Current State of Care.
    Tabuzo MMB; Hernandez MALU; Chua AE; Maningat PD; Chiu HHC; Jamora RDG
    Med Sci (Basel); 2024 Mar; 12(1):. PubMed ID: 38535157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bioinformatics-based approach and expression assay for identification of dysregulated genes in pituitary adenoma.
    Jamali E; Hashemnejad MA; Askari A; Shomali H; Eslami S; Akbari Dilmaghani N; Sharifi G; Bahranian A; Ghafouri-Fard S
    Pathol Res Pract; 2024 Jan; 253():155006. PubMed ID: 38056134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HTR2B suppresses non-functioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis.
    Lin S; Wang L; Han C; Dai Y; Li C; Liu Y; Zhang B; Huang N; Zhang A; Zhang T; Wang Y; Xie J; Tang H; Cheng Y; Yao H; Lou M; Xue L; Wu ZB
    Neuro Oncol; 2024 Jul; ():. PubMed ID: 38989697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification.
    Kim YS; Ahn S; Lee YS; Jeun SS; Park JS
    Pituitary; 2024 Jun; ():. PubMed ID: 38896347
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.